Fundraising Fox

ChromaDex

NASDAQ: NAGE

Irvine, US · Founded 1999 · Delaware corporation · 143 employees on LinkedIn · 2 known investors

Founders & leadership

ChromaDex was founded in 1999 by Frank Jaksch.

FJ

Frank JakschPresident and CEO

TV

Tom VarvaroCFO

TR

Troy RhonemusCOO

SB

Stephen BlockNamed on SEC filing

FL

Frank L. Jaksch, Jr.Chief Scientific Officer

GL

Glenn L. HalprynNamed on SEC filing

MB

Michael BrauserNamed on SEC filing

TC

Thomas C. VarvaroChief Financial Officer, Treasurer and Secretary

CA

Curtis A. LockshinNamed on SEC filing

JH

Jeffrey HimmelChief Executive Officer

MS

Mark S. GermainNamed on SEC filing

BH

Barry HonigNamed on SEC filing

Investors · 2

Horizons VenturesHong Kong · $1M – $110M

WELL VenturesreportedVancouvervia Hamed Shahbazi · board

Reported raises · per SEC filings

Form D private placements

$103.7M disclosed across 13 rounds · 2012–2022

▶$3.1MraisedOct 2022 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Brianna GerberExecutive Officer
Kristin PatrickDirector
Steven N. RubinDirector
Hamed ShahbaziDirector
Frank L. Jr. JakschDirector
Gary NgDirector
Robert N. FriedExecutive Officer, Director
Wendy YuDirector
Ann CohenDirector

Offering amount: $3.1M
Amount sold: $3.1M
First sale: Sep 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$25MraisedMar 2021 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Steven RubinDirector
Jeff BaxterDirector
Tony LauDirector
Wendy YuDirector
Mark FriedmanExecutive Officer
Frank L. JakschExecutive Officer, Director
Robert FriedExecutive Officer, Director
Kevin M. FarrExecutive Officer
Stephen L. BlockDirector
Kurt GustafsonDirector

Offering amount: $25M
Amount sold: $25M
First sale: Feb 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5MraisedMay 2020 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Wendy YuDirector
Megan JordanExecutive Officer
Tony LauDirector
Steven RubinDirector
Robert FriedExecutive Officer, Director
Mark FriedmanExecutive Officer
Frank JakschExecutive Officer, Director
Kevin FarrExecutive Officer
Jeff BaxterDirector
Kurt GustafsonDirector
Stephen BlockDirector

Offering amount: $5M
Amount sold: $5M
First sale: May 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$7MraisedAug 2019 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Frank L. JakschExecutive Officer, Director
Robert FriedExecutive Officer, Director
Kevin M. FarrExecutive Officer
Stephen BlockDirector
Kurt GustafsonDirector
Steven RubinDirector
Jeff BaxterDirector
Tony LauDirector
Wendy YuDirector
Mark FriedmanExecutive Officer
Lisa BratkovichExecutive Officer
Matthew RobertsExecutive Officer

Offering amount: $7M
Amount sold: $7M
Sales commissions: $175K
Placement agents: Oppenheimer & Co. Inc.
First sale: Aug 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$10MraisedMay 2019 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Frank L. JakschExecutive Officer, Director
Robert FriedExecutive Officer, Director
Kevin M. FarrExecutive Officer
Stephen BlockDirector
Kurt GustafsonDirector
Matthew RobertsExecutive Officer
Jeff BaxterDirector
Tony LauDirector
Wendy YuDirector
Mark FriedmanExecutive Officer
Lisa BratkovichExecutive Officer
Steven RubinDirector

Offering amount: $10M
Amount sold: $10M
Sales commissions: $250K
Placement agents: Oppenheimer & Co. Inc.
First sale: May 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$23MraisedNov 2017 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Stephen L. AllenDirector
Tsz Ho Tony LauDirector
Stephen A. BlockDirector
Kurt GustafsonDirector
Frank L. JakschExecutive Officer, Director
Jeff BaxterDirector
Robert FriedExecutive Officer, Director
Steven RubinDirector
Kevin FarrExecutive Officer
Wing Tak Wendy YuDirector
Troy RhonemusExecutive Officer

Offering amount: $23M
Amount sold: $23M
First sale: Nov 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.1MraisedAug 2017 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Tsz Ho Tony LauDirector
Jeff BaxterDirector
Kurt GustafsonDirector
Wing Tak Wendy YuDirector
Thomas VarvaroExecutive Officer
Stephen L. AllenDirector
Frank L. JakschExecutive Officer, Director
Troy RhonemusExecutive Officer
Stephen A. BlockDirector
Steven RubinDirector
Robert FriedExecutive Officer, Director

Offering amount: $5.1M
Amount sold: $5.1M
Placement agents: Ladenburg Thalmann and Co. Inc.
First sale: Aug 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$16.4MraisedJun 2017 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Frank L. JakschExecutive Officer, Director
Stephen L. AllenDirector
Jeff BaxterDirector
Troy RhonemusExecutive Officer
Steven RubinDirector
Thomas VarvaroExecutive Officer
Stephen A. BlockDirector
Robert FriedExecutive Officer, Director
Kurt GustafsonDirector

Offering amount: $16.4M
Amount sold: $16.4M
Finders' fees: $255K
Placement agents: Ladenburg Thalmann and Co. Inc.
First sale: May 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded ChromaDex?: ChromaDex was founded by Frank Jaksch in 1999.
Who are ChromaDex's investors?: ChromaDex's investors include Horizons Ventures, WELL Ventures.
How much funding has ChromaDex raised?: ChromaDex has disclosed $103.7M raised across 13 rounds.
Where is ChromaDex headquartered?: ChromaDex is headquartered in Irvine, US.